Company: NKLR
Filing Date: 2025-12-16
Form Type: 424B3
Source: 0001213900-25-121900
Chunk: 130

Company: Terra Innovatum Global N.V.
Filing Date: 2025-12-16
Form: 424B3
Chunk 130
---
 expense recognized for the directors’ and  
 officers’ tail insurance policy recorded in Note 3(k) |

| (c) | To reflect the removal of the previously recognized income                         
 from GSR III’s cash and investments held in Trust Account as the Trust Account was 
 released upon the Closing.                                                         |

| (d) | To reflect the transaction costs of Terra Innovatum of $2.7                                  
 million for certain strategic advisory fees, legal and tax structuring services, accounting  
 and audit services for historical financial statements, and marketing and investor relations 
 costs. None of these services were specific incremental costs directly attributable to the   
 offering and were expensed as incurred. This is a non-recurring item.                        |

| (f) | To reflect the recognition of stock-based compensation upon                                      
 the satisfaction of a performance condition (the Closing of the Business Combination) associated 
 with the transfer of certain GSR III Class B Ordinary Shares.                                    |

In November 2024, the Sponsor transferred a total of 30,000
GSR III Class B Ordinary Shares to three independent directors (10,000 each) at a purchase price of $0.00438 per share. Additionally,
in December 2024, the Sponsor transferred 225,000 GSR III Class B Ordinary Shares to a member of the management team, also at a purchase
price of $0.00438 per share. Although the shares were legally transferred in 2024, the awards were subject to a performance condition
(the Closing of the Business Combination). As such, in accordance with ASC 718, stock-based compensation was not recognized until the
Closing, when the performance condition was satisfied.

The grant date fair value of the shares was determined to
be $0.00438 per share, equal to the amount paid by the recipients. As a result, the total stock-based compensation expense recognized
was $0, as the fair value of the awards was fully offset by the amount initially received for the purchase of the shares.

<div align='center'>76</div>

| (g) | To reflect the reversal of Terra Innovatum’s historical interest expense of $726.0 thousand for the Bridge Loans for the               
 nine months ended September 30, 2025, as the unaudited pro forma condensed combined statement of operations for the nine months ended  
 September 30, 2025 reflects adjustments assuming that the adjustment reflecting the conversion of the Bridge Loans at the Closing that 
 was made to the unaudited pro forma condensed combined balance